Modern Genome-Based Vaccine Design
Sponsored by: EpiVax & iCubed
Venue: Pacifico Yokohama: 1-1-1, Minato Mirai, Nishi-ku, Yokohama, Japan
Friday November 16th, 9:00 am – 5:00 pm
Speakers:
Dr. Hiroshi Kiyono M.D.
-
Professor and Dean, Institute of Medical Science,
-
University of Tokyo
Dr. Annie De Groot M.D.
-
Professor and Director, Institute of Immunology and Informatics,
-
University of Rhode Island
-
CEO/CSO, EpiVax
Dr. Takuya Tsunoda, M.D., Ph.D.
-
President & CEO
-
OncoTherapy Science, Inc
Dr. Eric Gowans, Ph.D.
-
NHMRC Senior Research Fellow
-
University of Adelaide
Dr. Kenya Honda M.D.
-
Associate Professor, Department of Immunology
-
University of Tokyo
Dr. Niranjan Sardesai, Ph.D.
-
COO
-
Inovio Pharmaceuticals
Ms. Frances Terry
-
Bioinformatics Program Manager
-
EpiVax, Inc.
Conference Agenda
Modern Genome-Based Vaccine Design November 16, 2012 |
||
Time |
Presenter |
Topic |
9:30 |
Dr. Hiroshi Kiyono, M.D. Professor, University of Tokyo |
Introduction & Welcome |
9:45 |
Dr. Annie DeGroot, M.D. Professor, URI and CEO, EpiVax |
From Concept to Clinic: Epitope-driven Vaccine Development |
10:30 |
Break |
|
11:00 |
Dr. Niranjan Sardesai COO Inovio Pharmaceuticals |
DNA Vaccines: Update from the Clinic
|
11:30 |
Dr. Eric Gowans NHMRC Senior Research Fellow University of Adelaide |
Therapeutic HCV Vaccines Based on Dendritic Cell Delivery |
12:00 |
Ms. Frances Terry, Bioinformatics Program Manager EpiVax, Inc. |
Hands-On Demonstration of iVAX Web-based Vaccine Design Toolkit
|
13:00 |
Lunch (Provided) |
|
13:45 |
Dr. Kenya Honda, M.D. Associate Professor University of Tokyo |
Internal Influence: Interactions Between the Human Microbiome, Autoimmunity and Allergy |
14:20 |
Dr. Annie De Groot, M.D. Professor, URI and CEO, EpiVax |
Driving Immunogenicity & Tolerance: Epitope Networks |
15:00 |
Dr. Takuya Tsunoda, M.D., Ph.D. President & CEO OncoTherapy Science, Inc |
Development of therapeutic cancer vaccine using dual functioning peptide cocktail targeting oncoantigen and angiogenesis |
15:50 |
Break |
|
16:15 |
All Speakers |
Panel Discussion and Questions from Participants |
17:00 |
Close |